Trials / Completed
CompletedNCT01445262
Drug Use Investigation for XYZAL®
Drug Use Investigation for XYZAL
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,728 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This post-marketing surveillance study (PMS) is conducted to collect safety and efficacy data among subjects with allergic rhinitis, urticaria, eczema, dermatitis, skin irritation, prurigo or pruritus cutaneous who have never been treated with levocetirizine tablets before.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2011-10-03
- Last updated
- 2015-08-13
Source: ClinicalTrials.gov record NCT01445262. Inclusion in this directory is not an endorsement.